ES2973710T3 - Nuevos compuestos de bencimidamidas que comprenden un anillo de oxaborinina - Google Patents
Nuevos compuestos de bencimidamidas que comprenden un anillo de oxaborinina Download PDFInfo
- Publication number
- ES2973710T3 ES2973710T3 ES19729249T ES19729249T ES2973710T3 ES 2973710 T3 ES2973710 T3 ES 2973710T3 ES 19729249 T ES19729249 T ES 19729249T ES 19729249 T ES19729249 T ES 19729249T ES 2973710 T3 ES2973710 T3 ES 2973710T3
- Authority
- ES
- Spain
- Prior art keywords
- compound
- hydroxy
- dihydro
- trifluoromethyl
- benzo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1809378.1A GB201809378D0 (en) | 2018-06-07 | 2018-06-07 | Novel compounds |
| PCT/EP2019/064599 WO2019234075A1 (en) | 2018-06-07 | 2019-06-05 | Novel benzimidamides compounds comprising an oxaborinin ring |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2973710T3 true ES2973710T3 (es) | 2024-06-24 |
Family
ID=62975712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES19729249T Active ES2973710T3 (es) | 2018-06-07 | 2019-06-05 | Nuevos compuestos de bencimidamidas que comprenden un anillo de oxaborinina |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11352372B2 (enExample) |
| EP (1) | EP3802550B1 (enExample) |
| JP (1) | JP7317866B2 (enExample) |
| KR (1) | KR102661802B1 (enExample) |
| CN (2) | CN116217603A (enExample) |
| BR (1) | BR112020024740A2 (enExample) |
| ES (1) | ES2973710T3 (enExample) |
| GB (1) | GB201809378D0 (enExample) |
| WO (1) | WO2019234075A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200040103A1 (en) | 2018-03-14 | 2020-02-06 | Genentech, Inc. | Anti-klk5 antibodies and methods of use |
| GB201809378D0 (en) * | 2018-06-07 | 2018-07-25 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| AU2020349509A1 (en) | 2019-09-18 | 2022-03-31 | Genentech, Inc. | Anti-KLK7 antibodies, anti-KLK5 antibodies, multispecific anti-KLK5/KLK7 antibodies, and methods of use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2872962T3 (es) * | 2005-02-16 | 2021-11-03 | Anacor Pharmaceuticals Inc | Boronoftalidas para uso terapéutico |
| EP2225261B1 (en) * | 2007-12-03 | 2016-03-09 | Obe Therapy Biotechnology | Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism |
| EP3246034A1 (en) * | 2008-03-06 | 2017-11-22 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-inflammatory agents |
| DK3097085T3 (da) | 2014-01-23 | 2020-10-26 | Sixera Pharma Ab | Benzoxazinonderivater til behandling af hudsygdomme |
| SI3097084T1 (sl) | 2014-01-23 | 2021-01-29 | Sixera Pharma Ab | Novi zaviralci kalikreina 7 |
| GB201809378D0 (en) * | 2018-06-07 | 2018-07-25 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
-
2018
- 2018-06-07 GB GBGB1809378.1A patent/GB201809378D0/en not_active Ceased
-
2019
- 2019-06-05 JP JP2020567854A patent/JP7317866B2/ja active Active
- 2019-06-05 EP EP19729249.3A patent/EP3802550B1/en active Active
- 2019-06-05 US US16/972,732 patent/US11352372B2/en active Active
- 2019-06-05 ES ES19729249T patent/ES2973710T3/es active Active
- 2019-06-05 WO PCT/EP2019/064599 patent/WO2019234075A1/en not_active Ceased
- 2019-06-05 CN CN202310268678.7A patent/CN116217603A/zh active Pending
- 2019-06-05 CN CN201980037789.9A patent/CN112236433B/zh active Active
- 2019-06-05 KR KR1020217000497A patent/KR102661802B1/ko active Active
- 2019-06-05 BR BR112020024740-5A patent/BR112020024740A2/pt active IP Right Grant
-
2022
- 2022-05-06 US US17/738,097 patent/US11767333B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| GB201809378D0 (en) | 2018-07-25 |
| EP3802550A1 (en) | 2021-04-14 |
| CN112236433B (zh) | 2023-04-04 |
| JP2021530440A (ja) | 2021-11-11 |
| US11352372B2 (en) | 2022-06-07 |
| US20220267357A1 (en) | 2022-08-25 |
| JP7317866B2 (ja) | 2023-07-31 |
| WO2019234075A1 (en) | 2019-12-12 |
| BR112020024740A2 (pt) | 2021-03-23 |
| CN116217603A (zh) | 2023-06-06 |
| KR20210018464A (ko) | 2021-02-17 |
| US20210253604A1 (en) | 2021-08-19 |
| KR102661802B1 (ko) | 2024-04-26 |
| US11767333B2 (en) | 2023-09-26 |
| EP3802550B1 (en) | 2023-12-27 |
| CN112236433A (zh) | 2021-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2012216894B2 (en) | Selective FAK inhibitors | |
| JP6456392B2 (ja) | ３−アリール−５−置換イソキノリン−１−オン化合物及びその治療的使用 | |
| ES2606174T3 (es) | Procesos de síntesis de derivados de dihidropiridoftalazinona | |
| ES2430966T3 (es) | Inhibidores de MAPK/ERK cinasa | |
| US10550124B2 (en) | Atropisomerism for increased kinase inhibitor selectivity | |
| US11767333B2 (en) | Benzimidamides compounds comprising an oxaborinin ring | |
| AU2014225155B2 (en) | Pyridopyrimidine or pyrimidopyrimidine compound, preparation method, pharmaceutical composition and use thereof | |
| KR20210124409A (ko) | Tyk2 슈도키나제 리간드 | |
| JP2012527443A (ja) | 新規ピリミジン誘導体と、癌とさらなる疾患の治療におけるそれらの使用 | |
| WO2019007293A1 (zh) | 用作alk激酶抑制剂的化合物及其应用 | |
| EP4208448A1 (en) | Novel compounds | |
| EP2521726B1 (fr) | Dérivés de 5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine comme inhibiteurs de kinases camkii pour le traitement de maladies cardiovasculaires | |
| CN113735830B (zh) | 一类羟肟酸衍生物及其应用 | |
| EP4034107A1 (en) | Jak inhibitors | |
| CN107530313A (zh) | Pde10抑制剂以及相关组合物和方法 | |
| WO2007025776A2 (en) | Cysteine protease inhibitors | |
| KR20220051351A (ko) | Jak 억제제 | |
| HK1179945B (en) | Processes of synthesizing dihydropyridophthalazinone derivatives | |
| HK1217197B (en) | Pyridopyrimidine or pyrimidopyrimidine compound, preparation method, pharmaceutical composition and use thereof |